Leukocyte Surface Antigen CD47 Market Growth Drivers
The Leukocyte Surface Antigen CD47 Market growth is fueled by rising cancer prevalence, increasing investment in oncology R&D, and breakthroughs in immunotherapy. CD47-targeting therapies represent a paradigm shift in cancer treatment by blocking the "don't eat me" signal and enabling macrophage-mediated tumor cell destruction. Cancer therapy applications command the largest segment at...
0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior